Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasms × Other hematologic neoplasm × Clear all

NCT05895994 2026-02-03

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT05716113 2024-11-21

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT05902845 2024-11-21

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT05907603 2024-11-21

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT05707325 2024-07-24

Reboot-101

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT02181478 2020-12-04

Intra-Osseous Co-Transplant of UCB and hMSC

Phase EARLY_PHASE1 Completed

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00013533 2019-12-16

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

Phase EARLY_PHASE1 Completed

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Biphenotypic, Acute

NCT04011293 2019-07-08

A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Neoplasms, Recurrence, Hematologic Neoplasms